🇺🇸 methyphenidate in United States

52 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Product Substitution Issue — 11 reports (21.15%)
  2. Drug Ineffective — 8 reports (15.38%)
  3. Fatigue — 5 reports (9.62%)
  4. Somnolence — 5 reports (9.62%)
  5. Abnormal Behaviour — 4 reports (7.69%)
  6. Balance Disorder — 4 reports (7.69%)
  7. Condition Aggravated — 4 reports (7.69%)
  8. Depression — 4 reports (7.69%)
  9. Therapeutic Response Changed — 4 reports (7.69%)
  10. Abdominal Pain Upper — 3 reports (5.77%)

Source database →

Other Other approved in United States

Frequently asked questions

Is methyphenidate approved in United States?

methyphenidate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for methyphenidate in United States?

IRCCS Eugenio Medea is the originator. The local marketing authorisation holder may differ — check the official source linked above.